3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
12
Lung Neoplasms
9
Colorectal Neoplasms
8
Prostatic Neoplasms
7
Pancreatic Neoplasms
3
Ovarian Neoplasms
3
Colonic Neoplasms
3
Skin Carcinoma
2
Melanoma
2
Malignant Solid Neoplasm
2
Lymphoma
2
Hematopoietic and Lymphatic System Neoplasm
2
Hematologic Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Anatomic Stage I Breast Cancer AJCC v8
2
Advanced Malignant Solid Neoplasm
2
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Spondylitis, Ankylosing
1
Sleep Wake Disorders
1
Rectal Neoplasms
1
Pyloric Stenosis, Hypertrophic
1
Psoriasis
1
Prostate
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Papillomavirus Infections
1
Pain
1
Overweight
1
Obesity-Related Malignant Neoplasm
1
Obesity
1
Interventions
relugolix
2
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
2
Specimen Handling
2
Radiotherapy
2
Radiation
2
Magnetic Resonance Spectroscopy
2
Leuprolide
2
Goserelin
2
Biopsy
2
radium Ra 223 dichloride
1
luprolide acetate gel depot
1
histrelin
1
gallium 68 PSMA-11
1
enzalutamide
1
darolutamide
1
bicalutamide
1
Triptorelin Pamoate
1
Surgical Procedures, Operative
1
Salicylic Acid
1
Radiotherapy, Image-Guided
1
Radiosurgery
1
Radiation Dose Hypofractionation
1
Flutamide
1
Buserelin
1
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Prostate Adenocarcinoma
×
Early Intervention, Educational
×
90 days
×
Clear all
No trials found.